{"id":758718,"date":"2023-05-15T07:34:32","date_gmt":"2023-05-15T11:34:32","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\/"},"modified":"2023-05-15T07:34:32","modified_gmt":"2023-05-15T11:34:32","slug":"standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\/","title":{"rendered":"Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <em>Industry veteran Jeffrey Black brings 30 years of financial and operating leadership experience<\/em><br \/>\n        \n      <\/p>\n<p align=\"center\">\n        <em>Vikram Jog to become Special Advisor for transition period<\/em>\n      <\/p>\n<p>SOUTH SAN FRANCISCO, Calif., May  15, 2023  (GLOBE NEWSWIRE) &#8212; Standard BioTools Inc.\u00a0(Nasdaq: LAB), driven by a bold purpose \u2013\u00a0<em>Unleashing tools to accelerate breakthroughs in human health<\/em> \u2013 announced the appointment of Jeffrey Black as Senior Vice President and Chief Financial Officer effective today. Black will lead Standard BioTools\u2019 finance, accounting and investor relations functions, reporting to Michael Egholm, Ph.D., President and Chief Executive Officer. Vikram Jog will remain at the company for a period as Special Advisor to the CEO to ensure an effective transition.<\/p>\n<p>\u201cWe are excited to welcome Jeff to the Standard BioTools executive leadership team. Jeff has a proven track record of driving performance for high-growth public companies and his extensive operating experience and financial stewardship will be critical as Standard BioTools enters its next phase of growth,\u201d said Egholm. \u201cI also want to extend my gratitude to Vikram, who has been a steady hand and clear thinker as we navigated the strategic transformation throughout our first year as Standard Biotools.\u201d<\/p>\n<p>Mr. Black was most recently Chief Financial Officer at Apollo Endosurgery, Inc. until Apollo\u2019s acquisition by Boston Scientific in April 2023. Mr. Black has also served in senior finance leadership roles for seven publicly traded companies, including as Executive Vice President and Chief Financial Officer of Alphatec Holdings, Inc., a medical technology company. Previously, Mr. Black was Chief Financial Officer of Applied Proteomics, Inc., a proteomics-based diagnostics company, and as Chief Financial Officer of AltheaDx, Inc., a pharmacogenetics diagnostics company. Mr. Black began his career in the audit practice at EY. He is a member of the Board of Directors of Cellana, Inc., an algae bioproducts company, and received his B.S. in Business from the University of Arizona.<\/p>\n<p>\u201cI am thrilled to join this high-caliber leadership team and dynamic organization,\u201d said Black. \u201cThis team is building an exceptional company that will be the next great provider of solutions to researchers around the world. There is a tremendous opportunity ahead to greatly impact patient lives and unlock shareholder value. I am delighted to be a part of Standard BioTools as it continues to execute on its mission.\u201d<\/p>\n<p>As a material inducement for Mr. Black to commence employment with Standard BioTools, on May 15, 2023, Mr. Black will receive an award of non-statutory stock options to purchase 400,000 shares of the Company\u2019s common stock (\u201cOption Award\u201d). The Option Award will have a 10-year term and an exercise price per share equal to the closing price of the company\u2019s common stock as quoted on the Nasdaq Global Select Market on May 15, 2023. Subject to his continued employment with the company through the applicable vesting dates, 25% of the shares subject to the Option Award will vest on the first anniversary of the vesting commencement date, and the remaining 75% of the shares subject to the Option Award will vest in roughly equal monthly installments thereafter. In addition, as a material inducement for Mr. Black to commence employment with the company, on May 15, 2023 he will receive an award of restricted stock units valued at $400,000 (\u201cRSU Award\u201d) based on the closing price of the company\u2019s common stock on May 15, 2023. Subject to his continued employment with the company, 25% of the shares underlying the RSU Award will vest on the first anniversary of the vesting commencement date and the remaining 75% of the shares underlying the RSU Award will vest in roughly equal installments every three months thereafter until fully vested in May 2027. The Option Award and RSU Award will be subject to the terms of the company\u2019s 2022 Inducement Equity Incentive Plan and the applicable award agreements thereunder. In accordance with Nasdaq Listing Rule 5635(c)(4), a majority of the independent directors serving on the company\u2019s Board of Directors approved Mr. Black\u2019s inducement awards.<\/p>\n<p>\n        <strong>About Standard BioTools Inc.<\/strong>\u00a0<\/p>\n<p>Standard BioTools Inc. (Nasdaq: LAB), previously known as Fluidigm Corporation, is driven by a bold purpose \u2013\u00a0<em>Unleashing tools to accelerate breakthroughs in human health<\/em>.\u00a0Standard BioTools has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, the company provides reliable and repeatable insights in health and disease using its proprietary mass cytometry and microfluidics technologies, which help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. Learn more at www.standardbio.com or connect with us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lqQM4vpLHx0IFstwxgibEYJlJNx7ic4-SMHLycAiK03H3z6s-FA06Xu7Y-GQCYk7v61VjDyzQ39a5nsc8HzPqA==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter\u00ae<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=h4BoJ7DP1iinHiXcIehXwneQzu1j1uD7BUE8Bvao5flMIBatdv-UA-GJTctsPXZb4Dnx-3CD_6O1fVFDrNY0giHtZaYF75nxvuLQfj1VxIU=\" rel=\"nofollow noopener\" target=\"_blank\">Facebook\u00ae<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vtVCzt1V7nJd9gcoYjWSyI4RMWUAlQiKbWhCBmFnUjI88UK7gpLpJ38F_PT2LfrSNJP2tFhzfXw_3Tirpij7uGJOzpUxq_HJQiAs3gkM4rVrtksqs4TOI_whVjRtdumY\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>, and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NMsflQEBK6Vqg_4lm8-JiGnY4i5kwCY8F_ZXUlmrCahpNtjFw7ekVNkpxUVqFTUQXtViR_5vxk5s3ig0_1NDi18334QY7z7CIeg5LdQrlUZlwCtbxHp2yOj_s77pxK3UC1L2GyPzQgBvsU01GKhXlQ4KArC8qaaxYQUcOU58iY5Nut_MU8so7EhebhEbBZpC3Sls2QNUlwI0FxoK3HYAwoO2iPBWyUEeOalf77286MZhaYdpRCVJByKWs6-OIhfZwR94eoumVdwZwBVmNLhoJvLv3M7sX0B3eYuRVrh4Ct_T7knnz1pD3pLvIeDi1J_n\" rel=\"nofollow noopener\" target=\"_blank\">YouTube\u2122<\/a>. Standard BioTools, the Standard BioTools logo, Fluidigm, the Fluidigm logo, \u201cUnleashing tools to accelerate breakthroughs in human health,\u201d Hyperion, Hyperion XTi, XTi, and X9 are trademarks and\/or registered trademarks of\u00a0Standard BioTools Inc.\u00a0or its affiliates in\u00a0the United States\u00a0and\/or other countries. All other trademarks are the sole property of their respective owners. Standard BioTools\u00a0products are provided for\u00a0<strong>Research Use Only<\/strong>. Not for use in diagnostic procedures.<\/p>\n<p>\n        <strong>Available Information<\/strong>\u00a0<\/p>\n<p>Standard BioTools\u00a0uses its website (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=u9P9_dRsu3zcAG-03l33YTZ1gSIXQW90lmwMcC2aPeGzZfwoACKZjdc7rTlV_XlynsmxcIPncGRDuxr0VIl-YAZ6u9ouHnU9k7-Y_7Ts-Laie-iy5kVfF3T_UcpubGaomT0YwSLkW7lIU4PMQBmAi8z94CLxD3ewqHx1wGU9aULSH62o6ZHXOSnimKscbgui8f_a3bCP96wLyZJtTokE5bL08ZopgkFTCMhW4sqKzcTmOGo91k3WMmg8GvMrf0Zt\" rel=\"nofollow noopener\" target=\"_blank\"><u>standardbio.com<\/u><\/a>), investor site (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AOa_5vhdPej7a_SBncK4EgpxACALnJ3sOD22TthuXM-POZyj2CBgap91fg1cRq4J-B_6dLNfsy_wxji5ozlUrNNuKdCdDvQ-VIH6HRh0ue7OvLb0xZJlr0UYKkoKhCRH-aLPpfhtFK_9tLj8omb1bRUb5qYNYhQmbk6CMkoqsLw3i3Z3VNLNlsBYyG9pGWcbaGb_j2JVP6tWtnBaAQmTbpUvvkb6rMVdnEnhwrONBHo-hoZoLnJnJZqRn4B0LNGk-FAjwuCWpsqM58lg8stty27L3vnDN6H3jpzok1zEUA4=\" rel=\"nofollow noopener\" target=\"_blank\"><u>investors.standardbio.com<\/u><\/a>), corporate Twitter account (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bJjt614GXQmOOVkG4vE7-ECYkvqQHo-l8lDiN4LVcBc-9NWzO4A8T6cbhwOxztcT6adJUDqPyP0OD_DLkQkvy72JFmerSdmqf2BqhGBjTwA=\" rel=\"nofollow noopener\" target=\"_blank\"><u>@Standard_BioT<\/u><\/a>), Facebook page (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2Vhv-xeSIVoF9RHBLKOwNcgMwZxUtHvM-xvpMY-F8Cf7lwCf8nwgaJtFlHl65XLGWRp2czNobdGm3LMQWo1LLDnG7L3ZKYHut63chKdF4zLiVFRZtGtE0okXSaRS_FbJ\" rel=\"nofollow noopener\" target=\"_blank\"><u>facebook.com\/StandardBioT),<\/u><\/a> and LinkedIn page (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=enYQlLGfS194IjUEzVAegIJVwTgk57NjRz-UIgg0NJ8qYIrnop5uNxLF4ee-y2pOCmy3rebZLOE-NcdsprE14UngSny9C3qCQkxEd5MBpPeXCVdok4Rh52vS__LcoYow5xC6DpVZSbb_vQDlxSlxHMSWNrX5qN3bz-OwIj6-VLw=\" rel=\"nofollow noopener\" target=\"_blank\"><u>linkedin.com\/company\/standard-biotools<\/u><\/a>) as channels of distribution of information about its products, its planned financial and other announcements, its attendance at upcoming investor and industry conferences, and other matters. Such information may be deemed material information, and\u00a0Standard BioTools\u00a0may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Standard BioTools\u2019 website and its social media accounts in addition to following its press releases,\u00a0SEC\u00a0filings, public conference calls, and webcasts.\u00a0<\/p>\n<p>\n        <strong>Investor Contacts<\/strong>\u00a0<\/p>\n<p>Scott R. Greenstone, CFA<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xeyivVWwZRljxy0mtx-QuZJq_6K-xmITjMqMyelheDcNXQG12eicOag0zOh7RMGQrFzIy-ZjCKQJTU3Vjze-CYkkFACRhj-vxGtNWPjc4JE=\" rel=\"nofollow noopener\" target=\"_blank\"><u>ir@standardbio.com<\/u><\/a>\u00a0<\/p>\n<p>Peter DeNardo\u00a0<br \/>415 389 6400\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xeyivVWwZRljxy0mtx-QueEEY748zbZOS1zs0iJBX7qJsovGj7LeZhZXp_6CvLefXGWk15mLE0ZlfO_2VbYrRlEhAPZm3GC-O_qJlQwZ-z0=\" rel=\"nofollow noopener\" target=\"_blank\"><u>ir@standardbio.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzODk5NyM1NTk0Mzk4IzIwMDM4MTg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YzBlNTBlN2ItZDYxYy00OTE3LWIyMTAtMjdlMWIyM2ZlOTEzLTEwMTUzOTE=\/tiny\/Standard-BioTools-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Industry veteran Jeffrey Black brings 30 years of financial and operating leadership experience Vikram Jog to become Special Advisor for transition period SOUTH SAN FRANCISCO, Calif., May 15, 2023 (GLOBE NEWSWIRE) &#8212; Standard BioTools Inc.\u00a0(Nasdaq: LAB), driven by a bold purpose \u2013\u00a0Unleashing tools to accelerate breakthroughs in human health \u2013 announced the appointment of Jeffrey Black as Senior Vice President and Chief Financial Officer effective today. Black will lead Standard BioTools\u2019 finance, accounting and investor relations functions, reporting to Michael Egholm, Ph.D., President and Chief Executive Officer. Vikram Jog will remain at the company for a period as Special Advisor to the CEO to ensure an effective transition. \u201cWe are excited to welcome Jeff to the Standard BioTools executive leadership &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-758718","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Industry veteran Jeffrey Black brings 30 years of financial and operating leadership experience Vikram Jog to become Special Advisor for transition period SOUTH SAN FRANCISCO, Calif., May 15, 2023 (GLOBE NEWSWIRE) &#8212; Standard BioTools Inc.\u00a0(Nasdaq: LAB), driven by a bold purpose \u2013\u00a0Unleashing tools to accelerate breakthroughs in human health \u2013 announced the appointment of Jeffrey Black as Senior Vice President and Chief Financial Officer effective today. Black will lead Standard BioTools\u2019 finance, accounting and investor relations functions, reporting to Michael Egholm, Ph.D., President and Chief Executive Officer. Vikram Jog will remain at the company for a period as Special Advisor to the CEO to ensure an effective transition. \u201cWe are excited to welcome Jeff to the Standard BioTools executive leadership &hellip; Continue reading &quot;Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-15T11:34:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzODk5NyM1NTk0Mzk4IzIwMDM4MTg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)\",\"datePublished\":\"2023-05-15T11:34:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\\\/\"},\"wordCount\":980,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzODk5NyM1NTk0Mzk4IzIwMDM4MTg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\\\/\",\"name\":\"Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzODk5NyM1NTk0Mzk4IzIwMDM4MTg=\",\"datePublished\":\"2023-05-15T11:34:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzODk5NyM1NTk0Mzk4IzIwMDM4MTg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzODk5NyM1NTk0Mzk4IzIwMDM4MTg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\/","og_locale":"en_US","og_type":"article","og_title":"Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Market Newsdesk","og_description":"Industry veteran Jeffrey Black brings 30 years of financial and operating leadership experience Vikram Jog to become Special Advisor for transition period SOUTH SAN FRANCISCO, Calif., May 15, 2023 (GLOBE NEWSWIRE) &#8212; Standard BioTools Inc.\u00a0(Nasdaq: LAB), driven by a bold purpose \u2013\u00a0Unleashing tools to accelerate breakthroughs in human health \u2013 announced the appointment of Jeffrey Black as Senior Vice President and Chief Financial Officer effective today. Black will lead Standard BioTools\u2019 finance, accounting and investor relations functions, reporting to Michael Egholm, Ph.D., President and Chief Executive Officer. Vikram Jog will remain at the company for a period as Special Advisor to the CEO to ensure an effective transition. \u201cWe are excited to welcome Jeff to the Standard BioTools executive leadership &hellip; Continue reading \"Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-15T11:34:32+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzODk5NyM1NTk0Mzk4IzIwMDM4MTg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","datePublished":"2023-05-15T11:34:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\/"},"wordCount":980,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzODk5NyM1NTk0Mzk4IzIwMDM4MTg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\/","name":"Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzODk5NyM1NTk0Mzk4IzIwMDM4MTg=","datePublished":"2023-05-15T11:34:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzODk5NyM1NTk0Mzk4IzIwMDM4MTg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzODk5NyM1NTk0Mzk4IzIwMDM4MTg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-appoints-jeffrey-black-as-chief-financial-officer-and-announces-inducement-grants-under-nasdaq-listing-rule-5635c4\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/758718","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=758718"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/758718\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=758718"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=758718"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=758718"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}